Tissue-type plasminogen activator-plasmin-BDNF modulate glutamate-induced phase-shifts of the mouse suprachiasmatic circadian clock in vitro

European Journal of Neuroscience

Volumn 30, Issue 8, 2009, Pages 1451-1460

  Mou, Xiang ^a   Peterson, Cynthia B ^a   Prosser, Rebecca A ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Brain derived neurotrophic factor; Circadian rhythms; PAI 1; Suprachiasmatic; TPA; Vitronectin

Indexed keywords

ALPHA 2 ANTIPLASMIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; VITRONECTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CIRCADIAN RHYTHM; CONTROLLED STUDY; HIPPOCAMPUS; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PHOTOSTIMULATION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SUPRACHIASMATIC NUCLEUS; WILD TYPE;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CIRCADIAN RHYTHM; DRUG INTERACTIONS; FIBRINOLYSIN; GENE EXPRESSION REGULATION; GLUTAMIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PLASMINOGEN ACTIVATOR INHIBITOR 1; SUPRACHIASMATIC NUCLEUS; TISSUE PLASMINOGEN ACTIVATOR; VITRONECTIN;

EID: 70350234915     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2009.06946.x     Document Type: Article

References (68)

1. Ahn, M.Y., Zhang, Z.G., Tsang, W. Chopp, M. (1999) Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice. Brain Res., 837, 169 176. (Pubitemid 29369228)
2. Arroyo De Prada, N., Schroeck, F., Sinner, E.K., Muehlenweg, B., Twellmeyer, J., Sperl, S., Wilhelm, O.G., Schmitt, M. Magdolen, V. (2002) Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin. Eur. J. Biochem., 269, 184 192.
3. Brogren, H., Sihlbom, C., Wallmark, K., Linn, M., Deinum, J., Karlsson, L. Jern, S. (2008) Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin. Thromb. Res., 122, 271 281.
4. Butcher, G.Q., Lee, B. Obrietan, K. (2003) Temporal regulation of light-induced extracellular signal-regulated kinase activation in the suprachiasmatic nucleus. J. Neurophysiol., 90, 3854 3863.
5. Butcher, G.Q., Lee, B., Hsieh, F. Obrietan, K. (2004) Light- and clock-dependent regulation of ribosomal S6 kinase activity in the suprachiasmatic nucleus. Eur. J. Neurosci., 19, 907 915.
6. Butcher, G.Q., Lee, B., Cheng, H.-Y.M. Obrietan, K. (2005) Light stimulates MSK1 activation in the suprachiasmatic nucleus via a PACAP-ERK/MAP kinase-dependent mechanism. J. Neurosci., 25, 5305 5313.
7. Carmeliet, P. Collen, D. (1998) Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb. Res., 91, 255 285.
8. Cederholm- Williams, S.A. (1981) Concentration of plasminogen and antiplasmin in plasma and serum. J. Clin. Pathol., 34, 979 981.
9. Cheng, H.-Y.M., Dziema, H., Papp, J., Mathur, D.P., Koletar, M., Ralph, M.R., Penninger, J.M. Obrietan, K. (2006) The molecular gatekeeper dexras1 sculpts the photic responsiveness of the mammalian circadian clock. J. Neurosci., 26, 12984 12995.
10. Collen, D. Wiman, B. (1978) Fast-acting plasmin inhibitor in human plasma. Blood, 51, 563 569.
11. Devy, L., Blacher, S., Grignet-Debrus, C., Bajou, K., Masson, V., Gerard, R.D., Gils, A., Carmeliet, G., Carmeliet, P., Declerck, P.J., Nöel, A. Foidart, J.M. (2002) The pro- or antiangiogenitic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J., 16, 147 154.
12. Dietzmann, K., von Bossanyi, P., Kraus, D., Wittig, H., Mawrin, C. Kirches, E. (2000) Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study. Pathol. Res. Pract., 196, 15 21.
13. Ding, J.M., Chen, D., Weber, E.T., Faiman, L.E., Rea, M.A. Gillette, M.U. (1994) Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science, 266, 1713 1717.
14. Ding, J.M., Faiman, L.E., Hurst, W.J., Kuriashkina, L.R. Gillette, M.U. (1997) Resetting the biological clock: mediation of nocturnal CREB phosphorylation via light, glutamate, and nitric oxide. J. Neurosci., 17, 667 675.
15. Ding, J.M., Buchanan, G.F., Tischkau, S.A., Chen, D., Kuriashkina, L., Faiman, L.E., Alster, J.M., McPherson, P.S., Campbell, K.P. Gillette, M.U. (1998) A neuronal ryanodine receptor mediates light-induced phase delays of the circadian clock. Nature, 394, 381 384.
16. Fay, W.P., Eitzman, D.T., Shapiro, A.D., Madison, E.L. Ginsburg, D. (1994) Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms. Blood, 83, 351 356.
17. Fernandez-Monreal, M., Lopez- Atalaya, J.P., Benchenane, K., Cacquevel, M., Dulin, F., Le Caer, J.P., Rossier, J., Jarrige, A.-C., MacKenzie, E.T., Colloc'h, N., Ali, C. Vivien, D. (2004) Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling. J. Biol. Chem., 279, 50850 50856.
18. Gillette, M.U. Tischkau, S.A. (1999) Suprachiasmatic nucleus: the brain's circadian clock. Recent Prog. Horm. Res., 54, 33 59.
19. Gils, A., Pedersen, K.E., Skottrup, P., Christensen, A., Naessens, D., Deinum, J., Enghild, J.J., Declerck, P.J. Andreasen, P.A. (2003) Biochemical importance of glycosylation of plasminogen activator inhibitor-1. Thromb. Haemost., 90, 206 217.
20. Hino, H., Akiyama, H., Iseki, E., Kato, M., Kondo, H., Ikeda, K. Kosaka, K. (2001) Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissues. Neurosci. Lett., 297, 105 108.
21. Horwood, J.M., Ripley, T.L. Stephens, D.N. (2001) DRL performance in mice with deletion of tPA, uPA or PAI-1 genes. Behav. Pharmacol., 12, 487 496.
22. Huntington, J.A. Carrell, R.W. (2001) The serpins: nature's molecular mousetraps. Sci. Prog., 84, 125 136.
23. Isahara, K. Yamamoto, M. (1995) The interaction of vascular endothelial cells and dorsal root ganglion neurites is mediated by vitronectin and heparan sulfate proteoglycans. Brain Res. Dev. Brain Res., 84, 164 178.
24. Kjoller, L., Kanse, S.M., Kirkegaard, T., Rodenburg, K.W., Ronne, E., Goodman, S.L., Preissner, K.T., Ossowski, L. Andreasen, P.A. (1997) Plasminogen activator inhibitor-1 represses integrin-and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Exp. Cell Res., 232, 420 429.
25. Kokaia, Z., Bengzon, J., Metsis, M., Kokaia, M., Persson, H. Lingvall, O. (1993) Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc. Natl. Acad. Sci. U S A, 90, 6711 6715.
26. Kumada, M., Niwa, M., Wang, X., Matsuno, H., Hara, A., Mori, H., Matsuo, O., Yamamoto, T. Kozawa, O. (2004) Endogenous tissue type plasminogen activator facilitates NMDA-induced retinal damage. Toxicol. Appl. Pharmacol., 200, 48 53.
27. Kumada, M., Niwa, M., Hara, A., Matsuno, H., Mori, H., Ueshima, S., Matsuo, O., Yamamoto, T. Kozawa, O. (2005) Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade. Invest. Ophthalmol. Vis. Sci., 46, 1504 1507.
28. Lee, R., Kermani, P., Teng, K.K. Hempstead, B.L. (2001) Regulation of cell survival by secreted proneurotrophins. Science, 294, 1945 1948.
29. Liang, F.-Q., Walline, R. Earnest, D.J. (1998) Circadian rhythm of brain-derived neurotrophic factor in the rat suprachiasmatic nucleus. Neurosci. Lett., 242, 89 92.
30. Liang, F.-Q., Allen, G. Earnest, D. (2000) Role of brain-derived neurotrophic factor in the circadian regulation of the suprachiasmatic pacemaker by light. J. Neurosci., 20, 2978 2987.
31. Marpegan, L., Bekenschtein, T.A., Freudenthal, R., Rubio, M.F., Ferreyra, G.A., Romano, A. Golombek, D.A. (2004) Participation of transcription factors from the Rel/NF-kB family in the circadian system in hamsters. Neurosci. Lett., 358, 9 12.
32. Matys, T., Pawlak, R., Matys, E., Pavlides, C., McEwen, B.S. Strickland, S. (2004) Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior. Proc. Natl. Acad. Sci. U S A, 101, 16345 16350.
33. Mayasundari, A., Whittemore, N.A., Serpersu, E.H. Peterson, C.B. (2004) The solution structure of the N-terminal domain of human vitronectin: proximal sites that regulate fibrinolysis and cell migration. J. Biol. Chem., 279, 29359 29366.
34. Menger, G.J., Lu, K., Thomas, T., Cassone, V.M. Earnest, D.J. (2005) Circadian profiling of the transcriptome in immortalized rat SCN cells. Physiol. Genomics, 21, 370 381.
35. Michel, S., Clark, J.P., Ding, J.M. Colwell, C.S. (2006) Brain-derived neurotrophic factor and neurotrophin receptors modulate glutamate-induced phase shifts of the suprachiasmatic nucleus. Eur. J. Neurosci., 24, 1109 1116.
36. Minor, K.H. Peterson, C.B. (2002) PAI-1 promotes the self-association of vitronectin into complexes exhibiting altered incorporation into the extracellular matrix. J. Biol. Chem., 277, 10337 10345.
37. Moore, R.Y. Eichler, V.B. (1972) Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res., 42, 201 206.
38. Mowla, S.J., Farhadi, H.F., Pareek, S., Atwal, J.K., Morris, S.J., Seidah, N.G. Murphy, R.A. (2001) Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J. Biol. Chem., 176, 12660 12666.
39. Neuhoff, H., Roeper, J. Schweizer, M. (1999) Activity-dependent formation of perforated synapses in cultured hippocampal neurons. Eur. J. Neurosci., 11, 4241 4250.
40. Panda, S., Antoch, M.P., Miller, B.H., Su, A.I., Schook, A.B., Straume, M., Schultz, P.G., Kay, S.A., Takahashi, J.S. Hogenesch, J.B. (2002) Coordinated transcription of key pathways in the mouse by the circadian clock. Cell, 109, 307 320.
41. Pang, P.T., Teng, H.K., Zaitsev, E., Woo, N.T., Sakata, K., Zhen, S., Teng, K.K., Yung, W.-H., Hempstead, B.L. Lu, B. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science, 306, 487 491.
42. Pawlak, R., Melchor, J.P., Matys, T., Skrzypiec, A.E. Strickland, S. (2005) Ethanol-withdrawl seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. Proc. Natl. Acad. Sci. U S A, 102, 443 448.
43. Pizzio, G.A., Hainich, E.C., Ferreyra, G.A., Coso, O.A. Golombek, D.A. (2003) Circadian and photic regulation of ERK, JNK and p38 in the hamster SCN. Neuroreport, 14, 1417 1419.
44. Plow, E.F., Herren, T., Redlitz, A., Miles, L.A. Hoover- Plow, J.L. (1995) The cell biology of the plasminogen system. FASEB J., 9, 939 945.
45. Podor, T.J., Peterson, C.B., Lawrence, D.A., Stefansson, S., Shaughnessy, S.G., Foulon, D.M., Butcher, M. Weitz, J.I. (2000a) Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin. J. Biol. Chem., 275, 19788 19794.
46. Podor, T.J., Shaughnessy, S.G., Blackburn, M.N. Peterson, C.B. (2000b) New insights into the size and stoichiometry of the plasminogen activator inhibitor type-1, vitronectin complex. J. Biol. Chem., 275, 25402 25410.
47. Pollak, D.D., Herkner, K., Hoeger, H. Lubec, G. (2005) Behavioral testing upregulates pCaMKII, BDNF, PSD-95 and egr-1 in hippocampus of FVB/N mice. Behav. Brain Res., 163, 128 135.
48. Prosser, R.A. (1998) In vitro circadian rhythms of the mammalian suprachiasmatic nuclei: comparison of multiunit and singleunit neuronal activity recordings. J. Biol. Rhythms, 13, 30 38.
49. Prosser, R.A. (2003) Serotonin phase-shifts the mouse suprachiasmatic circadian clock in vitro. Brain Res., 966, 110 115.
50. + channel opening. Brain Res., 644, 67 73.
51. Prosser, R.A., Rutishauser, U., Ungers, G., Fedorkova, L. Glass, J.D. (2003) Intrinsic role of polysialylated neural cell adhesion molecule in photic phase resetting of the mammalian circadian clock. J. Neurosci., 23, 652 658.
52. Reilly, C.F. Hutzelmann, J.E. (1992) Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution. J. Biol. Chem., 267, 17128 17135.
53. Salles, F.J. Strickland, S. (2002) Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J. Neurosci., 22, 2125 2134.
54. Sappino, A.-P., Madani, R., Huarte, J., Belin, D., Kiss, J.Z., Wohlwend, A. Vassalli, J.-D. (1993) Extracellular proteolysis in the adult murine brain. J. Clin. Invest., 92, 679 685.
55. Seiffert, D. (1997) Constitutive and regulated expression of vitronectin. Histol. Histopathol., 12, 787 797.
56. Seiffert, D., Crain, K., Wagner, N.V. Loskutoff, D.J. (1994) Vitronectin gene expression in vivo: evidence for extrahepatic synthesis and acute phase regulation. J. Biol. Chem., 269, 19836 19842.
57. Seiffert, D., Bordin, G.M. Loskutoff, D.J. (1996) Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes. Histochem. Cell Biol., 105, 195 201.
58. Shin, C.Y., Kundell, M. Wells, D.G. (2004) Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation. J. Neurosci., 24, 9425 9433.
59. Soscia, S.J. Harrington, M.E. (2004) Neuropeptide Y attenuates NMDA-induced phase shifts in the SCN of NPY Y1 receptor knockout mice in vitro. Brain Res., 1023, 148 153.
60. Stephan, F.K. Zucker, I. (1972) Circadian rhythms in drinking behavior and locomotor activity or rats are eliminated by hypothalamic lesions. Proc. Natl. Acad. Sci. U S A, 69, 1583 1586.
61. Tischkau, S.A., Mitchell, J.W., Pace, L.A., Barnes, J.W., Barnes, J.A. Gillette, M.U. (2004) Protein kinase G type II is required for night-to-day progression of the mammalian circadian clock. Neuron, 43, 539 549.
62. Uchibori-Iwaki, H., Yoneda, A., Oda-Tamai, S., Kato, S., Akamatsu, N., Otsuka, M., Murase, K., Kojima, K., Suzuki, R., Maeya, Y., Tanabe, M. Ogawa, H. (2000) The changes in glycosylation after partial hepatectomy enhance collagen binding of vitronectin in plasma. Glycobiology, 10, 865 874.
63. Yannielli, P. Harrington, M.E. (2004) Let there be "more" light: enhancement of light actions on the circadian system through non-photic pathways. Prog. Neurobiol., 74, 59 76.
64. Yepes, M. Lawrence, D.A. (2004) Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system? Trends Cardiovasc. Med., 14, 173 180. (Pubitemid 38942824)
65. Yepes, M., Sandkvist, M., Coleman, T.A., Moore, E., Wu, J.-Y., Mitola, D., Bugge, T.H. Lawrence, D.A. (2002) Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. J. Clin. Invest., 109, 1571 1578.
66. Yepes, M., Sandkvist, M., Moore, E.G., Bugge, T.H., Strickland, D.K. Lawrence, D.A. (2003) Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest., 112, 1533 1540.
67. Zhang, Y., Pothakos, K. Tsirka, S.-A. (2005) Extracellular proteases: biological and behavioral roles in the mammalian central nervous system. Curr. Top. Dev. Biol., 66, 161 188.
68. Zheng, X., Saunders, T.L., Camper, S., Samuelson, L. Ginsburg, D. (1995) Vitronectin is not essential for normal mammalian development and fertility. Proc. Natl. Acad. Sci. U S A, 92, 12426 12430.